Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: High subjective and objective response in patients with symptomatic metastases: Editorial Comment

William K. Oh

Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: High subjective and objective response in patients with symptomatic metastases: Editorial Comment

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	1813
Number of pages	1
Journal	Journal of Urology
Volume	174
Issue number	5
State	Published - Nov 2005
Externally published	Yes

Cite this

@article{6cb38d997e104b5ab068c4b0392750c8,

title = "Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: High subjective and objective response in patients with symptomatic metastases: Editorial Comment",

author = "Oh, {William K.}",

year = "2005",

month = nov,

language = "English",

volume = "174",

pages = "1813",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

number = "5",

}

TY - JOUR

T1 - Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer

T2 - High subjective and objective response in patients with symptomatic metastases: Editorial Comment

AU - Oh, William K.

PY - 2005/11

Y1 - 2005/11

UR - http://www.scopus.com/inward/record.url?scp=27544464710&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:27544464710

SN - 0022-5347

VL - 174

SP - 1813

JO - Journal of Urology

JF - Journal of Urology

IS - 5

ER -